Clinical Trials
40 trialsObserving People With Desmoid-Type Fibromatosis
Memorial Sloan Kettering Cancer Center
Embodesmo
Istituto Ortopedico Rizzoli
ECT-DESMO
Istituto Ortopedico Rizzoli
Cryomics
Istituto Ortopedico Rizzoli
PRISM
Dana-Farber Cancer Institute
ALTITUDES
Centre Oscar Lambret
Immunological Phenotype of Desmoid-fibromatosis-affected Patients.
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
PALANGI3
Centre Oscar Lambret
RIPAF
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
SarcAblate
Oxford University Hospitals NHS Trust
CRYODESMO01
University Hospital, Strasbourg, France
CRYODESMO-02
University Hospital, Strasbourg, France
TAE-DESMO
Istituto Ortopedico Rizzoli
Tailored Beta-catenin Mutational Approach in Extra-abdominal Sporadic Desmoids Tumor Patients
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Study of Cryoablation and Nirogacestat for Desmoid Tumor
Stanford University
PROSa Desmoid
Technische Universität Dresden
Cryotherapy in the Treatment of Desmoid Tumors
Istituto Ortopedico Rizzoli
RCT of Two Noncrosslinked Porcine Acellular Dermal Matrices in Ab Wall Reconstruction
Ohio State University
Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers
Sarcoma Oncology Research Center, LLC
MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors
Children's National Research Institute
A Study to Evaluate the Safety and Efficacy of Vactosertib and Imatinib in Patients With Advanced Desmoid Tumor
Yonsei University
RFAdesmoid
Blokhin's Russian Cancer Research Center
CT-guided Radioactive Iodine-125 Seed Implantation for Recurrent Desmoid Tumors
Peking University Third Hospital
CARDT
University Hospital, Strasbourg, France
QUALIFIED
Erasmus Medical Center
A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis
MaineHealth
Desmoid Tumor and Pregnancy: Effect of Pregnancy on Disease Control and Effect of Diagnosis on Pregnancy History.
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
A Randomized, Double-blind,Phase â…¢ Study of Liposome Doxorubicin in Desmoid Tumor
Sun Yat-sen University
ABRADES
Grupo Espanol de Investigacion en Sarcomas
Doxorubicin Eluting Intra-arterial Embolization for Aggressive Desmoid Fibromatosis
Rabin Medical Center
Optional Sub-study to Intraoperative Imaging With ICG Registry
Abramson Cancer Center at Penn Medicine
18F-FES PET/CT in Imaging Patients With Desmoid Tumors
Vanderbilt-Ingram Cancer Center
HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors
University of Texas Southwestern Medical Center
Compassionate Use Protocol for PF-03084014 in Patients With Advanced Solid Tumor Malignancies
University of Colorado, Denver
Study to Evaluate Imatinib in Desmoid Tumors
Heidelberg University
Effect of Hydroxyurea as Treatment for Primary Desmoid Tumors
Children's Hospital of Philadelphia
Imatinib Mesylate in Treating Patients With Recurrent or Refractory Fibromatosis
UNICANCER
Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas
Memorial Sloan Kettering Cancer Center
Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular Targets
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
A Cohort Study of Patients Treated With Brachytherapy for Selected Desmoid Patients in Gardner Syndrome
Triemli Hospital